SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
Loading market information…
SHZ · 002262.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangsu Nhwa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangsu Nhwa Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.40 per share, paid annual. The forward yield is 1.85% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jiangsu Nhwa Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Mar 25, 2027, with estimated earnings per share of CN¥0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangsu Nhwa Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥1.46B-1.73% vs estimate |
| Q2 2025 | Jul 29, 2025 | CN¥0.390.0% vs estimate | CN¥1.50B-4.12% vs estimate |
|---|
| Q1 2025 | Apr 18, 2025 | CN¥0.30-3.23% vs estimate | CN¥1.51B0.0% vs estimate |
|---|
| Q4 2024 | Mar 28, 2025 | CN¥0.12-29.41% vs estimate | CN¥1.55B-6.05% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
CN¥49.03+CN¥0.41 (+0.84%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.52% below the high.
HK$51.30+HK$0.65 (+1.28%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.63% below the high.
CN¥179.20+CN¥0.20 (+0.11%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.18% below the high.
CN¥16.43+CN¥0.53 (+3.33%)
Zhejiang Huahai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 15.18% below the high.
CN¥19.54+CN¥0.04 (+0.21%)
Apeloa Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.44% below the high.
CN¥11.99+CN¥0.20 (+1.7%)
Beijing Aosaikang Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.53% below the high.
CN¥11.28+CN¥0.22 (+1.99%)
Zhejiang Jingxin Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.9% below the high.
